Preferred Label : Meropenem;

MeSH definition : A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients.;

MeSH hyponym : SM-7338; SM7338;

MeSH CAS label : 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))-;

MeSH Related Number : 96036-03-2 (Meropenem);

UNII : FV9J3JU8B1;

Details


Main resources

You can consult :

A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients.

https://www.has-sante.fr/jcms/p_3159918/fr/meropenem-hikma
2020
false
false
false
France
meropenem
drugs, generic
evaluation of the transparency committee
Meropenem
meropenem

---
https://www.has-sante.fr/jcms/p_3152689/fr/vaborem
2020
false
false
false
France
meropenem and vaborbactam
drug combinations
vaborbactam
beta-Lactamase Inhibitors
Meropenem
anti-bacterial agents
therapeutic uses
treatment outcome
insurance, health, reimbursement
enterobacteriaceae infections
infusions, intravenous
evaluation of the transparency committee
boronic acids

---
https://www.has-sante.fr/jcms/p_3148219/fr/meropenem-gerda
2020
false
false
false
France
meropenem
drugs, generic
evaluation of the transparency committee
Meropenem
meropenem

---
https://www.ema.europa.eu/en/medicines/human/EPAR/vabomere
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
vaborbactam
vaborbactam
beta-Lactamase Inhibitors
beta-Lactamase Inhibitors
meropenem and vaborbactam
anti-bacterial agents
anti-bacterial agents
adult
urinary tract infections
intraabdominal infections
pneumonia, bacterial
cross infection
pneumonia, ventilator-associated
infusions, intravenous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Gram-Negative bacterial infections
bacteremia
Hospital Acquired Pneumonia
boronic acids
boronic acids
thienamycins
thienamycins
Meropenem
Meropenem
Healthcare-Associated Pneumonia

---
https://www.has-sante.fr/portail/jcms/c_2886960/fr/meronem
2018
false
true
false
France
treatment outcome
infusions, intravenous
injections, intravenous
anti-bacterial agents
pneumonia, bacterial
cystic fibrosis
meropenem
insurance, health, reimbursement
evaluation of the transparency committee
thienamycins
Meropenem

---
https://www.has-sante.fr/portail/jcms/c_2880782/fr/meropenem-bradex
2018
false
false
false
France
drugs, generic
evaluation of the transparency committee
thienamycins
Meropenem

---
http://www.has-sante.fr/portail/jcms/c_2610506/fr/meronem
2016
false
France
French
infant
cross infection
urinary tract infections
intraabdominal infections
complicated skin and soft tissue infection
skin diseases, bacterial
soft tissue infections
meningitis, bacterial
pregnancy complications, infectious
infectious disease in mother complicating pregnancy, childbirth or puerperium, nos
Infection caused by antimicrobial resistant bacteria (disorder)
antibiotic therapy
evaluation of the transparency committee
infusions, intravenous
thienamycins
anti-bacterial agents
injections, intravenous
insurance, health, reimbursement
meropenem
pneumonia, bacterial
cystic fibrosis
treatment outcome
adult
child
aged
Meropenem

---
http://www.has-sante.fr/portail/jcms/c_2610188/fr/meronem
http://www.has-sante.fr/portail/jcms/c_713145/meronem
2016
false
France
French
antibiotic therapy
evaluation of the transparency committee
infusions, intravenous
thienamycins
anti-bacterial agents
injections, intravenous
insurance, health, reimbursement
meropenem
pneumonia, bacterial
cystic fibrosis
treatment outcome
adult
child
aged
Meropenem

---
http://www.has-sante.fr/portail/jcms/c_1649690/fr/meropenem-actavis
http://www.has-sante.fr/portail/jcms/c_1649689/fr/meropenem-actavis-18092013-avis-ct13120
2013
France
French
antibiotic therapy
evaluation of the transparency committee
meropenem
infusions, intravenous
injections, intravenous
drugs, generic
anti-bacterial agents
treatment outcome
adult
child
infant
adolescent
community-acquired infections
pneumonia, bacterial
cross infection
bronchopneumonia
urinary tract infections
intraabdominal infections
pregnancy complications, infectious
postpartum period
soft tissue infections
skin diseases, infectious
soft tissue infections
skin diseases, infectious
acute disease
meningitis, bacterial
cystic fibrosis
respiratory tract infections
thienamycins
Community acquired pneumonia
Meropenem

---
http://www.has-sante.fr/portail/jcms/c_1671497/fr/meropenem-stravencon
2013
France
evaluation of the transparency committee
Meropenem

---
http://www.lecrat.eu/?s=M%C3%A9rop%C3%A9nem
2013
France
French
antibiotic therapy
pregnancy
thienamycins
anti-bacterial agents
meropenem
thienamycins
drug information
Meropenem

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65943080
2012
France
summary of product characteristics
package leaflet
powders
Meropenem

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67710121
2012
France
summary of product characteristics
package leaflet
injections
powders
Meropenem

---
https://pgtmsite.files.wordpress.com/2024/01/meropenem_rum_ad_20120522.pdf
2012
Canada
drug information
Identifier
meropenem
Meropenem
Meropenem
Review
Analysis
Analyzed
Description
Meropenem
Use

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63443781
2012
France
summary of product characteristics
package leaflet
powders
Meropenem

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69858122
2012
France
summary of product characteristics
package leaflet
powders
Meropenem

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68710658
2012
France
summary of product characteristics
package leaflet
powders
Meropenem

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66973016
2012
France
summary of product characteristics
package leaflet
powders
injections
Meropenem

---
http://www.meddispar.fr/medicaments/3878306
2009
France
French
thienamycins
drug prescriptions
legislation, drug
injections, intravenous
meropenem
drug information
Meropenem

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F34F12H
2007
Belgium
vigilance note
valproic acid
Meropenem

---
Nous contacter.
05/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.